Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome. Graeme L Fraser et al

18/08/2021,
Serge Rozenberg
No data was found

Latest news

11/11/2025
BMS course on Menopause January 17, 2026